Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$6.9M Sell
211,584
-4,508
-2% -$146K 0.01% 1738
2014
Q2
$6.7M Sell
216,092
-24,574
-10% -$744K 0.01% 1697
2014
Q1
$7.35M Sell
240,666
-3,336
-1% -$101K 0.01% 1505
2013
Q4
$7.56M Buy
244,002
+64,068
+36% +$1.94M 0.01% 1497
2013
Q3
$4.61M Buy
179,934
+49,930
+38% +$1.18M ﹤0.01% 1777
2013
Q2
$2.75M Buy
+130,004
New +$2.76M ﹤0.01% 2194

Other funds holding STN

UBS's STN Position: Q3 2014 in Review

UBS reduced its Stantec (STN) stake by 2.1% in Q3 2014, selling an estimated $146K and leaving 211,584 shares worth $6.9M. The position accounts for 0.01% of the portfolio, ranked #1738.

UBS first reported a position in STN in Q2 2013 and has held it in 6 quarters since. The position peaked at $7.56M in Q4 2013. 111 funds tracked by Wall St. Rank hold STN as of Q3 2014.

  • UBS held 211,584 shares of Stantec worth $6.9M as of Q3 2014.
  • UBS sold 4,508 Stantec shares in Q3 2014, an estimated $146K.
  • Stantec made up 0.01% of UBS's portfolio in Q3 2014, its #1738 holding.
  • UBS first reported a position in Stantec in Q2 2013 and has held it in 6 quarters since.
  • UBS's Stantec position peaked at $7.56M in Q4 2013.
  • 111 funds tracked by Wall St. Rank held Stantec as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.